Intravénás immunglobulin-kezelés idiopathiás inflammatoricus myopathiákban

Translated title of the contribution: Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy

Levente Bodoki, Melinda Vincze, Zoltán Griger, K. Dankó

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Idiopathic inflammatory myopathies are chronic, systemic autoimmune diseases, characterized by symmetric and progressive weakness of proximal muscles in the upper and lower extremities. Treatment of the disease presents a complex challenge and it needs practical knowledge. In this review the authors summarize current treatment options, and discuss intravenous immunoglobulin treatment in therapy-unresponsive cases. Relevant data from the international literature is collected, too. Benefits and side effects of this treatment are also disclosed. Orv. Hetil., 2013, 154, 723-728.

Original languageHungarian
Pages (from-to)723-728
Number of pages6
JournalOrvosi Hetilap
Volume154
Issue number19
DOIs
Publication statusPublished - May 1 2013

Fingerprint

Myositis
Intravenous Immunoglobulins
Muscle Weakness
Autoimmune Diseases
Lower Extremity
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Intravénás immunglobulin-kezelés idiopathiás inflammatoricus myopathiákban. / Bodoki, Levente; Vincze, Melinda; Griger, Zoltán; Dankó, K.

In: Orvosi Hetilap, Vol. 154, No. 19, 01.05.2013, p. 723-728.

Research output: Contribution to journalArticle

Bodoki, Levente ; Vincze, Melinda ; Griger, Zoltán ; Dankó, K. / Intravénás immunglobulin-kezelés idiopathiás inflammatoricus myopathiákban. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 19. pp. 723-728.
@article{0430a619ed9b4489babeb41bea87823d,
title = "Intrav{\'e}n{\'a}s immunglobulin-kezel{\'e}s idiopathi{\'a}s inflammatoricus myopathi{\'a}kban",
abstract = "Idiopathic inflammatory myopathies are chronic, systemic autoimmune diseases, characterized by symmetric and progressive weakness of proximal muscles in the upper and lower extremities. Treatment of the disease presents a complex challenge and it needs practical knowledge. In this review the authors summarize current treatment options, and discuss intravenous immunoglobulin treatment in therapy-unresponsive cases. Relevant data from the international literature is collected, too. Benefits and side effects of this treatment are also disclosed. Orv. Hetil., 2013, 154, 723-728.",
keywords = "basis therapy, idiopathic infl ammatory myopathy, intravenous immunoglobulin, steroid",
author = "Levente Bodoki and Melinda Vincze and Zolt{\'a}n Griger and K. Dank{\'o}",
year = "2013",
month = "5",
day = "1",
doi = "10.1556/OH.2013.29600",
language = "Hungarian",
volume = "154",
pages = "723--728",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "19",

}

TY - JOUR

T1 - Intravénás immunglobulin-kezelés idiopathiás inflammatoricus myopathiákban

AU - Bodoki, Levente

AU - Vincze, Melinda

AU - Griger, Zoltán

AU - Dankó, K.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Idiopathic inflammatory myopathies are chronic, systemic autoimmune diseases, characterized by symmetric and progressive weakness of proximal muscles in the upper and lower extremities. Treatment of the disease presents a complex challenge and it needs practical knowledge. In this review the authors summarize current treatment options, and discuss intravenous immunoglobulin treatment in therapy-unresponsive cases. Relevant data from the international literature is collected, too. Benefits and side effects of this treatment are also disclosed. Orv. Hetil., 2013, 154, 723-728.

AB - Idiopathic inflammatory myopathies are chronic, systemic autoimmune diseases, characterized by symmetric and progressive weakness of proximal muscles in the upper and lower extremities. Treatment of the disease presents a complex challenge and it needs practical knowledge. In this review the authors summarize current treatment options, and discuss intravenous immunoglobulin treatment in therapy-unresponsive cases. Relevant data from the international literature is collected, too. Benefits and side effects of this treatment are also disclosed. Orv. Hetil., 2013, 154, 723-728.

KW - basis therapy

KW - idiopathic infl ammatory myopathy

KW - intravenous immunoglobulin

KW - steroid

UR - http://www.scopus.com/inward/record.url?scp=84877276835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877276835&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29600

DO - 10.1556/OH.2013.29600

M3 - Article

VL - 154

SP - 723

EP - 728

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 19

ER -